Apollo endosurgery reports qtrly loss per share of $0.30

Apollo endosurgery inc- qtrly loss per share $0.30.apollo endosurgery inc - second quarter revenue was $5.6 million, a decrease of approximately 60% compared to the second quarter of 2019.apollo endosurgery inc - cash, cash equivalents and restricted cash were $19.7 million as of june 30, 2020.apollo endosurgery inc - second quarter cash used in operating and investing activities was consistent with pre-pandemic quarterly levels.apollo endosurgery inc - submitted a 510k for the x-tack endoscopic helix tacking system for the treatment of gastrointestinal defect closures.
APEN Ratings Summary
APEN Quant Ranking